The University of Chicago Header Logo

In vivo cell cycle phase-preferential killing of murine fibrosarcoma cells by cisplatin.

In vivo cell cycle phase-preferential killing of murine fibrosarcoma cells by cisplatin. Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):845-51.

View in: PubMed